Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ando

Showing results (601-610 of 19,430) with videos related to

Pageof 1,943
Sort By:
Japanese Journal of Cancer Research : Gann|February 1, 1996
Therapeutic drug monitoring of etoposide in a 14-day infusion for non-small-cell lung cancerY Ando, H Minami, H Saka, et al.
Molecular Cancer Therapeutics|June 9, 2023
Identification of 2',4',6'-Trihydroxyacetophenone as Promising Cysteine Conjugate Beta-Lyase Inhibitor for Preventing Cisplatin-Induced NephrotoxicityNao Sukeda, Hidetsugu Fujigaki, Tatsuya Ando, et al.
British Journal of Cancer|January 1, 1997
Adjustment of creatinine clearance improves accuracy of Calvert's formula for carboplatin dosingY Ando, H Minami, H Saka, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 1, 1997
Prognostic value of pleural effusion in patients with non-small cell lung cancerS Sugiura, Y Ando, H Minami, et al.
Japanese Journal of Cancer Research : Gann|August 1, 1996
Therapeutic drug monitoring in 21-day oral etoposide treatment for lung cancerY Ando, H Minami, H Saka, et al.
The Science of the Total Environment|March 9, 2023
Impact of the COVID-19 pandemic on the prevalence of influenza A and respiratory syncytial viruses elucidated by wastewater-based epidemiologyHiroki Ando, Warish Ahmed, Ryo Iwamoto, et al.
Molecular Cancer Therapeutics|May 10, 2023
Identification of 2',4',6'-trihydroxyacetophenone as promising cysteine conjugate beta-lyase inhibitor for preventing cisplatin-induced nephrotoxicityNao Sukeda, Hidetsugu Fujigaki, Tatsuya Ando, et al.
Kyobu Geka. the Japanese Journal of Thoracic Surgery|December 20, 2022
[Current Status and Future Perspectives of Implantable Ventricular Assist Device]Masahiko Ando, Minoru Ono
International Immunology|July 28, 2022
CD8 T-cell heterogeneity during T-cell exhaustion and PD-1-targeted immunotherapySatomi Ando, Koichi Araki
Pharmaceutical Statistics|August 26, 2010
Practical issues and lessons learned from multi-regional clinical trials via case examples: a Japanese perspectiveYuki Ando, Toshimitsu Hamasaki
Pageof 1,943

Showing results (601-610 of 19,430) with videos related to

Sort By:
Pageof 1,943
Japanese Journal of Cancer Research : Gann|February 1, 1996
Therapeutic drug monitoring of etoposide in a 14-day infusion for non-small-cell lung cancerY Ando, H Minami, H Saka, et al.
Molecular Cancer Therapeutics|June 9, 2023
Identification of 2',4',6'-Trihydroxyacetophenone as Promising Cysteine Conjugate Beta-Lyase Inhibitor for Preventing Cisplatin-Induced NephrotoxicityNao Sukeda, Hidetsugu Fujigaki, Tatsuya Ando, et al.
British Journal of Cancer|January 1, 1997
Adjustment of creatinine clearance improves accuracy of Calvert's formula for carboplatin dosingY Ando, H Minami, H Saka, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 1, 1997
Prognostic value of pleural effusion in patients with non-small cell lung cancerS Sugiura, Y Ando, H Minami, et al.
Japanese Journal of Cancer Research : Gann|August 1, 1996
Therapeutic drug monitoring in 21-day oral etoposide treatment for lung cancerY Ando, H Minami, H Saka, et al.
The Science of the Total Environment|March 9, 2023
Impact of the COVID-19 pandemic on the prevalence of influenza A and respiratory syncytial viruses elucidated by wastewater-based epidemiologyHiroki Ando, Warish Ahmed, Ryo Iwamoto, et al.
Molecular Cancer Therapeutics|May 10, 2023
Identification of 2',4',6'-trihydroxyacetophenone as promising cysteine conjugate beta-lyase inhibitor for preventing cisplatin-induced nephrotoxicityNao Sukeda, Hidetsugu Fujigaki, Tatsuya Ando, et al.
Kyobu Geka. the Japanese Journal of Thoracic Surgery|December 20, 2022
[Current Status and Future Perspectives of Implantable Ventricular Assist Device]Masahiko Ando, Minoru Ono
International Immunology|July 28, 2022
CD8 T-cell heterogeneity during T-cell exhaustion and PD-1-targeted immunotherapySatomi Ando, Koichi Araki
Pharmaceutical Statistics|August 26, 2010
Practical issues and lessons learned from multi-regional clinical trials via case examples: a Japanese perspectiveYuki Ando, Toshimitsu Hamasaki
Pageof 1,943